Matches 1 - 50 out of 168 1 2 3 4 >


Match Document Document Title
US20110240512 Antibiotic Formulations Providing Reduced Gastrointestinal Side Effects and Clostridium difficile Infection Relapse, and Related Methods  
The invention includes a formulation comprising: (i) a therapeutically effective amount of at least one antibiotic; and (ii) a therapeutically effective amount of at least one probiotic material....
US20140065210 PROTEIN STABILIZED PROBIOTICS AND PERSONAL CARE PRODUCTS  
The present invention relates to a personal care product comprising a protein matrix wherein said protein matrix comprises at least one protein, at least one probiotic and a carrier fluid. The...
US20110052538 PROBIOTIC/NON-PROBIOTIC COMBINATIONS  
This invention pertains to a method of promoting gastrointestinal health by ingesting a composition comprising one or more probiotic microorganisms, one or more carbohydrate sources, and one or...
US20140079669 FORMULATION AND METHOD FOR TREATING PLANTS TO CONTROL OR SUPPRESS A PLANT PATHOGEN  
The present invention provides formulations and methods for preventing, suppressing, treating, or controlling pre- or post-harvest disease or decay in plants. In the inventive method, plants are...
US20110189143 FORMULATION AND METHOD FOR TREATING PLANTS TO CONTROL OR SUPPRESS A PLANT PATHOGEN  
The present invention provides formulations and methods for preventing, suppressing, treating, or controlling pre- or post-harvest disease or decay in plants. In the inventive method, plants are...
US20120003317 STABLE PROBIOTIC GRANULATE, AND METHOD FOR PREPARING SAME  
The invention pertains to the field of probiotic compositions useful for human and/or animal food and health. The invention particularly relates to compositions containing stable probiotic...
US20150056175 COMPOSITION FOR PREVENTING AND/OR TREATING DERMATOSIS AND METHOD FOR OBTAINING SAME  
A composition for preventing and/or treating dematosis, in particular psoriasis, and to a method for obtaining the same, which includes chamomile, thyme, bay leaf, hops, millet, barley malt,...
US20140186318 PROBIOTIC CONTROLLING FUNGI AND USES THEREOF  
A method for controlling detrimental oral organisms in various individuals includes administering a priobiotic composition that includes one or more species or strains of beneficial fungi and/or...
US20140112985 METHOD OF PREVENTION AND TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION  
This invention relates to prophylactic and/or therapeutic application of microorganism species that are, for example, administered orally as delayed release formulation designed to release its...
US20110256207 WHOLE GRAIN FLOUR AND PRODUCTS INCLUDING SAME  
The present invention is a grain product. The grain product includes a first fraction including bran. The first fraction is milled to a first particle size of less than 500 micrometers. The grain...
US20130129695 METHODS FOR TREATING OR INHIBITING INFECTION BY CLOSTRIDIUM DIFFICILE  
The invention provides methods for treating or inhibiting infection by Clostridium difficile in a subject in need of such treatment, comprising administering an effective amount of a compound...
US20110262411 BACTERIOPHAGE DERIVED METHODS TO CONTROL LACTIC ACID BACTERIAL GROWTH  
Compositions and methods for protection against bacterial contamination are disclosed Antibacterial proteins and methods of use thereof are also disclosed
US20150174074 MULTIPLE UNIT DOSAGE FORM HAVING A THERAPEUTIC AGENT IN COMBINATION WITH A NUTRITIONAL SUPPLEMENT  
Compositions and methods for combination therapy are provided. The compositions comprise a multiple unit dosage form having both a therapeutic agent and a nutritional supplement. The combination...
US20110300109 COMPOSITIONS AND METHODS FOR TREATING CANCER  
The present invention is based, in part, on our discovery of compositions and methods that can be used to systemically deplete arginine and thereby treat arginine-dependent cancers. Our studies...
US20140205581 FORMULATIONS CONTAINING SACCHAROMYCES BOULARDII AND SUPEROXIDE DISMUTASE (SOD) TO CONTROL OBESITY  
Disclosed is a composition containing Saccharomyces cerevisiae var boulardii and the enzyme superoxide dismutase.
US20090181001 METHOD OF PRODUCING DRY YEAST CONTAINING S-ADENOSYL-L-METHIONINE AND COMPOSITION FOR ORAL INTAKE  
A method for producing a dry yeast containing S-adenosyl-L-methionine using a yeast having production capability of S-adenosyl-L-methionine, in which a yeast cell concentrate separated from a cell...
US20120164121 ACTIVE INGREDIENT THAT IS OBTAINED FROM CANDIDA SAITOANA AND COSMETIC USE FOR DETOXIFYING SKIN CELLS  
The object of the invention is the use of Candida saitoana or an active ingredient that is obtained from Candida saitoana as a cosmetic active ingredient, in particular for the detoxification of...
US20150132271 READY TO EAT COLD BEVERAGE CAKES WITH INGREDIENTS  
Cold and ready to eat beverage cakes, and with a variety of ingredient combinations are suitable for healthy consumption. The beverage cakes are soft in texture and high in nutrition. People can...
US20120276201 COMPOSITIONS AND METHOD FOR TREATMENT AND PROPHYLAXIS OF INFLAMMATORY BOWEL DISEASE  
Methods and compositions for treating inflammatory bowel disease involve the use of targeted antibiotics in combination with probiotic formulations. The probiotics mitigate many of the deleterious...
US20120003198 Lutein/Zeaxanthin for glare protection  
The invention relates to the improvement of visual performance, particularly of visual performance in the darkness, by administration of a colorant that is capable of being incorporated into eye...
US20130089532 ADIPONECTIN PRODUCTION ACCELERATING COMPOSITION  
A problem to be solved is to provide an orally ingestible composition which promotes the production of adiponectin and which is free from safety issues such as side effects and toxicity. An...
US20110135616 Medicinal Product for Treating Gastrointestinal Ulcers  
The present invention relates to yeast cells for use in the prevention or treatment of gastric or intestinal ulcers.
US20130115195 Anti-Aging Formulations  
A dietary supplement based on fucoidan, blue-green algae, phycocyanin and phenylethylamine is fortified with one or more of curcumin, silymarin, resveratrol, astragalus root extract, astragoloside...
US20130028878 S-ADENOSYL-L-METHIONINE-CONTAINING DRY YEAST COMPOSITION WITH EXCELLENT STORAGE STABILITY AND PROCESS FOR PRODUCING SAME  
A dry yeast composition which includes 5-adenosyl-L-methionine and a thickener and has excellent storage stability. A thickener is added to a yeast cell concentrate obtained by culturing yeast...
US20120276056 Method for Use of Biologic Agents Including Live or Dormant Forms of Bacteria and other organisms in Treating Infections, Inflammation and Other Diseases of Distal Small Intestine and Large Intestine  
The present invention relates to method of treating distal gastrointestinal diseases including infections, inflammations and functional motility disorders by oral administration of therapeutic or...
US20150079055 USE OF SECRETOR, LEWIS AND SIALYL ANTIGEN LEVELS IN CLINICAL SAMPLES AS PREDICTORS OF RISK FOR DISEASE  
An individual at risk for necrotizing enterocolitis and related disorders can be identified by measuring the level of at least one secretor antigen in a biological sample from the individual and...
US20140140970 Use of Secretor, Lewis and Sialyl Antigen Levels in Clinical Samples as Predictors of Risk for Disease  
An individual at risk for necrotizing enterocolitis and related disorders can be identified by measuring the level of at least one secretor antigen in a biological sample from the individual and...
US20150125435 Compositions for Controlling Plant Parasitic Nematodes and Methods for Using Same  
Aspects of the invention include compositions for controlling plant parasitic nematodes. Compositions according to certain embodiments include a carbon skeleton energy compound, a chelating agent,...
US20150064263 COMPOSITIONS AND METHODS FOR REDUCTION OF MERCURY TOXICITY  
Provided are compositions containing melatonin and zinc. Additionally provided are dosage forms containing the compositions, and methods of making the compositions and dosage forms. Methods of...
US20080254010 Controlling Clostridium difficile-Associated Disease in the Gastrointestinal Tract  
This document provide materials and methods for treating patients infected with a spore-forming bacteria and materials and methods for preventing development of Clostridium difficile-associated...
US20090208470 Microorganisms Having Bad Smell Removal Activity of Organic Waste and Use Thereof  
The present invention relates to novel microorganisms having the efficiency of removing an offensive odor from organic waste and the use thereof. More particularly, the novel microorganisms have...
US20110223137 COMPOSITIONS FOR USE IN LOW-BIRTH WEIGHT INFANTS  
The present invention relates to compositions for use in low-birth weight infants. In particular, the compositions are probiotic compositions which are used for achieving full enteral feeding in...
US20150238403 LOW VISCOUS COSMETIC COMPOSITION USING A NATURAL EMULSIFYING AGENT  
The present invention relates to a low-viscosity cosmetic composition using a natural emulsifying agent. More specifically, the present invention relates to a cosmetic composition using a...
US20120282233 FUNGI ANTAGONISTIC TO XYLELLA FASTIDIOSA  
The disclosure describes fungal organisms and preparations useful for inhibiting infection by Xylella sp. and in the treatment of Pierce's Disease.
US20110123501 GUT FLORA AND WEIGHT MANAGEMENT  
The present invention relates to supporting weight management, weight loss and/or to the prevention and/or treatment of metabolic disorders. In particular the present invention relates to...
US20130330309 NUTRACEUTICAL AND PHARMACEUTICAL COMPOSITION  
According to a first aspect, a composition comprises selenium, vitamin C, and at least 90% by weight of native or undenatured whey protein. According to a second aspect, a composition consists of...
US20110189244 APPETISING MEDICAMENT FOR ORAL ADMINISTRATION IN SOLID FORM  
The invention relates to a coating composition for application to a veterinary pharmaceutical composition for oral administration, by a film coating method, comprising a powder appetising material...
US20150250835 COMPOSITION AND METHOD OF LACTOBACILLUS REUTERI GMNL-89 IN TREATING TYPE 2 DIABETES  
Present invention features a novel use of Lactobacillus for treating type 2 diabetes, wherein the Lactobacillus is Lactobacillus reuteri GMNL-89 with the deposition numbers of BCRC 910340 and...
US20120034201 COMPOSITION FOR REGULATING LIPID METABOLISM  
This invention concerns a nutraceutical and/or food composition for regulating, among other things, lipid metabolism in humans and animals, and methods of use of said nutraceutical and/or food...
US20150004148 METHODS AND COMPOSITIONS FOR INCREASING RNA INTERFERENCE  
The present invention relates to compositions containing a combination of a first active component comprising one or more sulfated polysaccharides and/or glycosaminoglycans and a second active...
US20110301030 SACCHAROMYCES CEREVISIAE STRAINS WITH PHYTOSANITARY CAPABILITIES  
The invention relates to a strain of Saccharomyces cerevisae characterized in that it is selected from strain No. I-3936 deposited on Mar. 4 2008 at the CNCM, strain No. I-3937 deposited on Mar. 4...
US20140112899 USE OF AN ENAMINOCARBONYL COMPOUND IN COMBINATION WITH A BIOLOGICAL CONTROL AGENT  
A combination comprising an enaminocarbonyl compound of formula (I): wherein R is methyl, cyclopropyl or 2,2-difluoroethyl, and at least one biological control agent selected from bacteria, fungi...
US20110117194 PHARMACEUTICAL FORMULATION CONTAINING ANGIOTENSIN-II RECEPTOR BLOCKER  
The present invention provides a pharmaceutical formulation containing an angiotensin-II receptor blocker and a release-control material as a pharmacologically active ingredient and a...
US20100330055 DISEASE RESISTANCE ENHANCER FOR PLANTS AND METHOD OF CONTROLLING PLANT DISEASE BY USING THE SAME  
Infection of pathogens is controlled by inducing disease resistance with a method of treating a plant with a composition of an acidic heat-treated solution of microorganisms.
US20130302278 USE OF TLR AGONISTS AND/OR TYPE 1 INTERFERONS TO ALLEVIATE TOXICITY OF TNF-R AGONIST THERAPEUTIC REGIMENS  
Improved (safer and more effective) methods of therapy using TNF-R agonists, e.g., CD40 agonists are provided. These methods provide for the addition of an amount of a type 1 interferon and/or a...
US20110014278 Compositions Comprising Dehydrated Micro-Organisms, Method for Preparing Same, and Uses Thereof  
The invention relates to a composition comprising revivable dehydrated micro-organisms. The invention is characterised in that it further comprises particles at least 50% of which have a mean...
US20110262412 BACTERIOCIN BASED METHODS TO CONTROL LACTIC ACID BACTERIAL GROWTH  
The present invention relates to compositions and methods for protection against bacterial contamination. The invention provides bactericidal yeast expressing bacteriocin proteins and methods of...
US20090269322 COMPOSITIONS COMPRISING SELENIUM-RICH YEAST AND YEAST BETA-GLUCAN  
A nutritional composition comprising by weight: between 0.05 and 30% selenium-enriched yeast; between 1 and 90% yeast beta-glucan; between 0.5 and 60% Vitamin C; and between 0.5 and 40% Vitamin E....
US20140205580 Combinations of Fungicidally Active Yeast and Fungicides  
Compositions are provided that improve overall plant vigor and yield by combining agriculturally effective amounts of at least one environmentally friendly biological control agent and at least...
US20110033433 Combinations of Fungicidally Active Yeast and Fungicides  
Compositions are provided that improve overall plant vigor and yield by combining agriculturally effective amounts of at least one environmentally friendly biological control agent and at least...

Matches 1 - 50 out of 168 1 2 3 4 >